B

Blue Jet Healthcare Ltd
NSE:BLUEJET

Watchlist Manager
Blue Jet Healthcare Ltd
NSE:BLUEJET
Watchlist
Price: 526.2 INR 0.28% Market Closed
Market Cap: 91.3B INR

Blue Jet Healthcare Ltd
Total Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Blue Jet Healthcare Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
Blue Jet Healthcare Ltd
NSE:BLUEJET
Total Current Assets
₹10.1B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Current Assets
₹279.6B
CAGR 3-Years
17%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Current Assets
₹249.2B
CAGR 3-Years
16%
CAGR 5-Years
13%
CAGR 10-Years
11%
Divi's Laboratories Ltd
NSE:DIVISLAB
Total Current Assets
₹100.8B
CAGR 3-Years
6%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Total Current Assets
₹168B
CAGR 3-Years
12%
CAGR 5-Years
5%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Current Assets
₹61.7B
CAGR 3-Years
8%
CAGR 5-Years
2%
CAGR 10-Years
2%
No Stocks Found

Blue Jet Healthcare Ltd
Glance View

Market Cap
91.3B INR
Industry
N/A

Blue Jet Healthcare Ltd is a IN-based company operating in industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2023-11-01. Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.

BLUEJET Intrinsic Value
466.02 INR
Overvaluation 11%
Intrinsic Value
Price
B

See Also

What is Blue Jet Healthcare Ltd's Total Current Assets?
Total Current Assets
10.1B INR

Based on the financial report for Mar 31, 2025, Blue Jet Healthcare Ltd's Total Current Assets amounts to 10.1B INR.

What is Blue Jet Healthcare Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
22%

Over the last year, the Total Current Assets growth was 43%. The average annual Total Current Assets growth rates for Blue Jet Healthcare Ltd have been 22% over the past three years .

Back to Top